February 2017
Global Cardiac Rhythm Management Devices Market to Reach $26.5 Billion by 2021
Cardiac Rhythm Management Devices help in the treatment of abnormal heart conditions by the use of pacemakers and implantable cardioverter defibrillators (ICDs).
Cardiac Rhythm Management Devices revenues are expected to reach $26.5 billion annually by 2021 with compound annual growth rate of 4.8%. North America accounts for the maximum growth of Cardiac Rhythm Management Devices with a market share of 39% whereas Europe accounts for 29% of market share. The maximum growth of Cardiac Rhythm Management Devices is being generated from the Pacemakers market.
Cardiac Rhythm Management Devices market is driven by new technology innovations and aging population. These devices have become less invasive and significant advances in pacing and pulse generator technology have enabled effective long-term device therapy with limited complications.
Medtronic is the market leader in the Cardiac Rhythm Management market. Some other major players on the market include Biotronik SE & Co. KG, Boston Scientific Corporation, Sorin S.p.A. and St. Jude Medical, Inc.
This report provides the Cardiac Rhythm Management Devices Market Forecasting Model, offers valuable insights on global evolution, regional variation, and current market trends. The report also provides Company Profiles with Pipeline Products and financials. Most of the products are being developed collaboratively between pharmaceutical and diagnostics companies.
Scope:
.png)
